SXPRX
Price
$49.14
Change
+$0.50 (+1.03%)
Updated
Jun 6 closing price
Net Assets
1.37B
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

SXPRX vs VITSX

Header iconSXPRX vs VITSX Comparison
Open Charts SXPRX vs VITSXBanner chart's image
DWS S&P 500 Index R6
Price$49.14
Change+$0.50 (+1.03%)
VolumeN/A
Net Assets1.37B
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
SXPRX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SXPRX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SXPRX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. SXPRX (1.37B). VITSX pays higher dividends than SXPRX: VITSX (1.29) vs SXPRX (1.06). SXPRX was incepted earlier than VITSX: SXPRX (8 years) vs VITSX (28 years). SXPRX (0.23) is less costly to investors than VITSX (0.03). SXPRX (2.00) and VITSX (2.00) have comparable annual turnover. SXPRX has a lower initial minimum investment than VITSX: SXPRX (0) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. SXPRX (8.49). VITSX return over 5 years is better than : 80.96 vs. SXPRX (56.65).
SXPRXVITSXSXPRX / VITSX
Total Expense Ratio0.230.03767%
Annual Report Gross Expense Ratio0.230.03767%
Fund Existence8 years28 years-
Gain YTD2.4930.833299%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.37B1.82T0%
Annual Yield % from dividends1.061.2982%
Returns for 1 year8.4910.9777%
Returns for 3 years29.9440.3574%
Returns for 5 years56.6580.9670%
Returns for 10 yearsN/A180.49-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.